About this resource:
Source: Centers for Disease Control and Prevention
Last Reviewed: March 2018
Workgroups: HIV Workgroup
This clinical practice guideline provides information about the use of pre-exposure prophylaxis (PrEP) to reduce people’s risk of getting HIV. This is an update to an earlier guideline, and revisions are meant to update the evidence base or to clarify specific points in clinical care. There were no changes to graded recommendations for the use of PrEP.
Objectives related to this resource (1)
Centers for Disease Control and Prevention. (2018). US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf